期刊的影响因子--文章列表

期刊文章列表
Qunjie Bi¹，Xu Song²，Yangyang Zhao¹，Xueyi Hu¹，Huan Yang¹，Rongrong Jin¹，Yu Nie¹（National Engineering Research Center for Biomaterials，College of Biomedical Engineering，Sichuan University；NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial & Institute of Regulatory Science for Medical Devices & NMPA Research Base of Regulatory Science for Medical Devices，Sichuan University）.Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses[J].Acta Pharmaceutica Sinica B,2023,第3期 Zheng Zhou，Keying Li，Yongchao Chu，Chao Li，Tongyu Zhang，Peixin Liu，Tao Sun，Chen Jiang（Department of Pharmaceutics，School of Pharmacy，Fudan University，Key Laboratory of Smart Drug Delivery，Ministry of Education，State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science）.ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Xing Duan¹，Yi Zhang²，Mengran Guo²，Na Fan¹，Kepan Chen¹，Shugang Qin¹，Wen Xiao¹，Qian Zheng¹，Hai Huang¹，Xiawei Wei¹，Yuquan Wei¹，Xiangrong Song¹（Department of Critical Care Medicine，Department of Clinical Pharmacy，Frontiers Science Center for Disease-related Molecular Network，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University；West China Hospital，Sichuan University）.Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine[J].Acta Pharmaceutica Sinica B,2023,第3期 Xin Jin^1,2,3，Shuai Wang^1,2，Limin Zhao^1,2,3，Wenjuan Huang^1,2，Yinxiang Zhang^1,2，Christophe Pannecouque⁴，Erik De Clercq⁴，Ge Meng^1,2，Huri Piao³，Fener Chen^1,2,3（Engineering Center of Catalysis and Synthesis for Chiral Molecules，Department of Chemistry，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs；Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules，Ministry of Education，College of Pharmacy，Yanbian University；Rega Institute for Medical Research，KU Leuven）.Development of fluorine-substituted NH₂-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors：Boosting the safety and metabolic stability[J].Acta Pharmaceutica Sinica B,2023,第3期 Sae-Bom Yoon^1,2，Hyowon Hong¹，Hee-Jong Lim¹，Ji Hye Choi¹，Yoon Pyo Choi³，Seong Wook Seo³，Hyuk Woo Lee³，Chong Hak Chae¹，Woo-Kyu Park¹，Hyun Young Kim¹，Daeyoung Jeong¹，Tran Quang De¹，Chang-Seon Myung²，Heeyeong Cho¹（Therapeutics & Biotechnology Division，Korea Research Institute of Chemical Technology；Department of Pharmacology，Chungnam National University College of Pharmacy；Future Medicine Co.Ltd.Rm616 LH-Business Growth Center）.A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhe Chen^1,2，Chaoyang Meng^1,3，Junhua Mai¹，Yongbin Liu¹，Hangwen Li⁴，Haifa Shen^1,5（Department of Nanomedicine，Houston Methodist Academic Institute；Xiangya Hospital of Central South University；Department of Hepatobiliary and Pancreatic Surgery，First Affiliated Hospital，Zhejiang University School of Medicine；Stemirna Therapeutics；Immuno Q Therapeutics）.An mRNA vaccine elicits STING-dependent antitumor immune responses[J].Acta Pharmaceutica Sinica B,2023,第3期 Xueqin Huang，Bingbing Sheng，Hemi Tian，Qiuxia Chen，Yingqi Yang，Brian Bui²，Jiang Pi³，Huaihong Cai³，Shanze Chen，Jianglin Zhang，Wei Chen²，Haibo Zhou，Pinghua Sun（The Second Clinical Medical College (Shenzhen People’s Hospital)，College of Pharmacy，Jinan University；Department of Physics，the University of Texas at Arlington；Department of Chemistry，Jinan University）.Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhuo Feng¹，Yuchen Wang¹，Haiheng Xu¹，Yunfei Guo¹，Wen Xia¹，Chenxuan Zhao¹，Xiaozhi Zhao²，Jinhui Wu^1,3（State Key Laboratory of Pharmaceutical Biotechnology，Chemistry and Biomedicine Innovation Center，Medical School of Nanjing University；Department of Andrology，Drum Tower Hospital，Medical School of Nanjing University；Jiangsu Key Laboratory for Nano Technology，Nanjing University）.Recent advances in bacterial therapeutics based on sense and response[J].Acta Pharmaceutica Sinica B,2023,第3期 Minxuan Xu^1,2,3，Jun Tan^1,2，Liancai Zhu³，Chenxu Ge^1,2,3，Wei Dong⁴，Xianling Dai^1,3，Qin Kuang^1,3，Shaoyu Zhong^1,2，Lili Lai^1,2，Chao Yi^1,2，Qiang Li^1,2，Deshuai Lou^1,2，Linfeng Hu^1,2,3，Xi Liu^1,2，Gang Kuang^1,2，Jing Luo^1,2，Jing Feng³，Bochu Wang³（Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region，School of Biological and Chemical Engineering，Chongqing University of Education；College of Modern Health Industry，Chongqing University of Education；Key Laboratory of Biorheological Science and Technology (Chongqing University)，Ministry of Education，College of Bioengineering，Chongqing University；Shandong Cancer Hospital and Institute，Shandong First Medical University & Shandong Academy of Medical Sciences）.The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Xingcai Zhang¹，Luo Hai²，Yibo Gao^2,3,4,5，Guocan Yu⁶，Yingli Sun^3,7,8（School of Engineering and Applied Sciences，Harvard University；Central Laboratory，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Thoracic Surgery，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Laboratory of Translational Medicine，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology，Department of Chemistry，Tsinghua University；University of Chinese Academy of Sciences；CAS Key Laboratory of Genome Sciences and Information，Beijing Institute of Genomics，Chinese Academy of Sciences/China National Center for Bioinformation）.Lipid nanomaterials-based RNA therapy and cancer treatment[J].Acta Pharmaceutica Sinica B,2023,第3期 Tengjie Yu¹，Zhihao Zhou¹，Shijia Liu²，Changjian Li¹，Zhi-Wei Zhang³，Yong Zhang³，Wei Jin¹，Keanqi Liu¹，Shuying Mao¹，Lei Zhu²，Lin Xie¹，Guangji Wang¹，Yan Liang¹（Key Lab of Drug Metabolism & Pharmacokinetics，State Key Laboratory of Natural Medicines，China Pharmaceutical University；Affliated Hospital of Nanjing University of Chinese Medicine；College of Chemical & Pharmaceutical Engineering，Hebei University of Science & Technology）.The role of phosphatidylcholine 34：1 in the occurrence,development and treatment of ulcerative colitis[J].Acta Pharmaceutica Sinica B,2023,第3期 Qian Zhou¹，Meiling Le¹，Yiyi Yang¹，Wenjuan Wang²，Yuqi Huang¹，Quan Wang¹，Yijing Tian¹，Meiyan Jiang¹，Yong Rao^2,3，Hai-Bin Luo^1,2,3，Yinuo Wu¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute，School of Pharmaceutical Sciences，Hainan University；Song Li' Academician Workstation of Hainan University (School of Pharmaceutical Sciences)）.Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia：Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis[J].Acta Pharmaceutica Sinica B,2023,第3期 Lu Zhang¹，Xiaolei Zhou²，Bowen Liu³，Xuhe Shi¹，Xianmeng Li¹，Feifei Xu¹，Xueli Fu¹，Xue Wang¹，Kai Ye¹，Tianzhi Jin¹，Huimin Sun¹，Qianqian Li¹，Weiying Zhang¹，Lihong Ye¹（State Key Laboratory of Medicinal Chemical Biology，Tianjin Key Laboratory of Protein Sciences，Department of Biochemistry and Molecular Biology，College of Life Sciences，Nankai University；College of Food Science & Biology，Hebei University of Science and Technology；Henan Key Laboratory of Immunology and Targeted Drugs，School of Laboratory Medicine，Xinxiang Medical University）.HBXIP blocks myosin-ⅡA assembly by phosphorylating and interacting with NMHC-ⅡA in breast cancer metastasis[J].Acta Pharmaceutica Sinica B,2023,第3期 Xiaoli Wei¹，Fan Yin^2,3，Miaomiao Wu^1,3，Qianqian Xie^3,4，Xueqin Zhao^3,4，Cheng Zhu¹，Ruiqian Xie^3,4，Chongqing Chen^3,4，Menghua Liu^3,4，Xueying Wang¹，Ruixue Ren¹，Guijie Kang^3,4，Chenwen Zhu¹，Jingjing Cong^3,4，Hua Wang^1,4，Xuefu Wang^3,4（Department of Oncology，the First Affiliated Hospital of Anhui Medical University；Department of Pharmacy，Huainan First People's Hospital，the First Affiliated Hospital of Anhui University of Science and Technology；School of Pharmacy，Anhui Medical University；Inflammation and Immune Mediated Diseases Laboratory of Anhui Province，Anhui Medical University）.G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes[J].Acta Pharmaceutica Sinica B,2023,第3期 Ling-Ling Wu^1,2,3，Qinxin Zhao^1,2,3，Qinghua Wang¹，Qingyang Zhang¹，Feiya Yang^2,3，Bo Zheng⁴，Hai-Yu Hu¹，Nianzeng Xing^2,3,5（State Key Laboratory of Bioactive Substances and Function of Natural Medicine，Institute of Materia Medica，Peking Union Medical College and Chinese Academy of Medical Sciences；Department of Urology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Pathology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Urology，Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital，Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University）.Membrane dual-targeting probes：A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection[J].Acta Pharmaceutica Sinica B,2023,第3期 Shiyang Shen，Teng Li，Jinyi Fan，Quanlin Shao，He Dong，Xiao Xu，Ran Mo（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases，Center of Advanced Pharmaceuticals and Biomaterials，School of Life Science and Technology，China Pharmaceutical University）.Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor[J].Acta Pharmaceutica Sinica B,2023,第3期 Senlin Li^1,2，Siyu Chen³，Zhihui Dong¹，Xingdong Song²，Xiuling Li¹，Ziqi Huang²，Huiru Li²，Linzhuo Huang¹，Ganyuan Zhuang¹，Ran Lan²，Mingyan Guo⁴，Wende Li³，Phei Er Saw¹，Lei Zhang²（Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Guangdong-Hong Kong Joint Laboratory for RNA Medicine，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Department of Hepatobiliary Surgery，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Guangdong Laboratory Animals Monitoring Institute，Guangdong Key Laboratory of Laboratory Animals；Department of Anesthesiology，Sun Yat-sen Memorial Hospital，Sun Yat-sen University）.Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer[J].Acta Pharmaceutica Sinica B,2023,第3期 Keliang Chen¹，Tao Wang²，Yong Li¹，Jun Wu¹，Cheng-Xiao Zhao¹，Sheng Liu¹，Fengrun Sun²，Yehong Fang²，Jiahuan Hu¹，Jinping Hu¹，Chong-Jing Zhang¹，Haibo Yu¹，Chao Ma²，Shi-Shan Yu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Institute of Basic Medical Sciences，Neuroscience Center，Chinese Academy of Medical Sciences，Department of Human Anatomy，Histology and Embryology，School of Basic Medicine，Peking Union Medical College）.Rhodojaponin Ⅵ indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain[J].Acta Pharmaceutica Sinica B,2023,第3期 Yanfang Yang¹，Ke Feng²，Liying Yuan¹，Yuxin Liu¹，Mengying Zhang³，Kaimin Guo³，Zequn Yin⁴，Wenjia Wang³，Shuiping Zhou^5,6，He Sun^3,5,6，Kaijing Yan^3,5,6，Xijun Yan^5,6，Xuerui Wang⁴，Yajun Duan^4,7，Yunhui Hu³，Jihong Han^1,4（College of Life Sciences，State Key Laboratory of Medicinal Chemical Biology，Key Laboratory of Bioactive Materials of Ministry of Education，Nankai University；Department of Physiology，Binzhou Medical University；Cloudphar Pharmaceuticals Co.Ltd.；Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes，Hefei University of Technology；The State Key Laboratory of Core Technology in Innovative Chinese Medicine，Tasly Academy，Tasly Holding Group Co.Ltd.；Tasly Pharmaceutical Group Co.Ltd.；Department of Cardiology，the First Affiliated Hospital of USTC，Division of Life Science and Medicine，University of Science and Technology of China）.Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhihui Dong^1,2，Zhuoshan Huang^1,2，Senlin Li^1,2，Ying Wang^1,2，Yandan Yao^1,2，Xianzhu Yang³，Xiaoding Xu^1,2（Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；RNA Biomedical Institute，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；School of Biomedical Sciences and Engineering，South China University of Technology，Guangzhou International Campus）.Nanoparticles（NPs）-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Jiang Wu¹，Wenfeng Gou²，Zhiyun Wang³，Huajie Chang³，Deguan Li²，Wenbin Hou²，Changxiao Liu⁴（Department of Pharmaceutical Engineering，School of Chemical Engineering and Technology，Tianjin University；Institute of Radiation Medicine，Chinese Academy of Medical Sciences；School of Chinese Materia Medica，Tianjin University of Traditional Chinese Medicine；Research Center for New Drug Evaluation，the State Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research）.Discovery of the radio-protecting effect of Ecliptae Herba,its constituents and targeting p53-mediated apoptosis in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第3期 Ning Shao¹，Xueyang Ma²，Ying-Ying Zhang¹，Donghui Yang²，Ming Ma²，Gong-Li Tang^1,3（State Key Laboratory of Bioorganic and Natural Products Chemistry，Center for Excellence in Molecular Synthesis，Shanghai Institute of Organic Chemistry，University of Chinese Academy of Sciences，Chinese Academy of Sciences；State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；School of Chemistry and Materials Science Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences）.Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis[J].Acta Pharmaceutica Sinica B,2023,第3期 Juanjuan Feng^1,2，Zhengke Lian¹，Xinting Xia¹，Yue Lu¹，Kewen Hu³，Yunpeng Zhang¹，Yanan Liu¹，Longmiao Hu¹，Kun Yuan¹，Zhenliang Sun²，Xiufeng Pang¹（Shanghai Key Laboratory of Regulatory Biology，School of Life Sciences，East China Normal University；Joint Center for Translational Medicine，Southern Medical University Affiliated Fengxian Hospital；Cancer Institute，Fudan University Shanghai Cancer Center，Department of Oncology，Shanghai Medical College，Fudan University）.Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer[J].Acta Pharmaceutica Sinica B,2023,第3期（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2023,第3期 Haowen Xu^1,2，Jiahao Chen¹，Pan Chen¹，Weifeng Li¹，Jingjing Shao^1,2，Shanshan Hong¹，Yi Wang¹，Lingfeng Chen²，Wu Luo^1,3，Guang Liang^1,2（Chemical Biology Research Center，School of Pharmaceutical Sciences，Wenzhou Medical University；School of Pharmaceutical Sciences，Hangzhou Medical College；Medical Research Center，the First Affiliated Hospital of Wenzhou Medical University）.Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases[J].Acta Pharmaceutica Sinica B,2023,第2期 Chen Fu^1,2，Lifeng Yu¹，Yuxi Miao^1,2,3，Xinli Liu⁴，Zhaojin Yu^1,2，Minjie Wei^1,2,3（Department of Pharmacology，School of Pharmacy，China Medical University；Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation，China Medical University；Liaoning Medical Diagnosis and Treatment Center；Department of Digestive Oncology，Cancer Hospital of China Medical University，Liaoning Cancer Hospital&Institute）.Peptide-drug conjugates（PDCs）：a novel trend of research and development on targeted therapy, hype or hope?[J].Acta Pharmaceutica Sinica B,2023,第2期 Lujing Geng¹，Tong Lu²，Huaqing Jing¹，Yue Zhou¹，Xiaoyang Liang¹，Jiao Li²，Nan Li¹（Tianjin Key Laboratory of Drug Delivery&High-Efficiency，School of Pharmaceutical Science and Technology，Tianjin University；School of Precision Instruments and Optoelectronics Engineering，Tianjin University）.Iron-based and BRD₄-downregulated strategy for amplified ferroptosis based on pH-sensitive/NIR-Ⅱ-boosted nano-matchbox[J].Acta Pharmaceutica Sinica B,2023,第2期 Tao He，Mingxing Hu，Shunyao Zhu，Meiling Shen，Xiaorong Kou，Xiuqi Liang，Lu Li，Xinchao Li，Miaomiao Zhang，Qinjie Wu，Changyang Gong（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University）.A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence[J].Acta Pharmaceutica Sinica B,2023,第2期 Meng Chen^1,2，Zhengyan Guo^1,3，Jinyuan Sun^1,2，Wei Tang^1,2，Min Wang^1,4，Yue Tang¹，Pengwei Li¹，Bian Wu^1,2，Yihua Chen^1,2（State Key Laboratory of Microbial Resources&CAS Key Laboratory of Microbial Physiological and Metabolic Engineering，Institute of Microbiology，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Laboratory of Microbial Metabolic Engineering，Institute of Medicinal Biotechnology，Chinese Academy of Medical Science&Peking Union Medical College；School of Biotechnology and Health Sciences，Wuyi University）.Insights into the biosynthesis of septacidin L-heptosamine moiety unveils a VOC family sugar epimerase[J].Acta Pharmaceutica Sinica B,2023,第2期首页上一页 7 8 9 10 11 下一页尾页共有11页，转到页

期刊文章列表